Document Detail

The mechanism of antiproliferative effect of desferrioxamine on human hepatoma cell lines.
MedLine Citation:
PMID:  8009898     Owner:  NLM     Status:  MEDLINE    
We investigated the effect of desferrioxamine (DFO), an iron chelator, on the DNA synthesis and the cell cycle of cultured hepatoma cells. Using Hep 3B cells as the hepatoma cell lines, DNA synthesis was measured by [3H] thymidine incorporation, and the cell cycle analysis was performed by flow cytometry including bivariate DNA/BrdU analysis. [3H] thymidine uptake was decreased by DFO in a dose dependent manner. The proportion of S phase cells increased and that of G0/G1 phase cells decreased after the addition of DFO in the culture media in a dose dependent manner up to 20 micrograms/ml of DFO. The S phase duration of the exponentially proliferating Hep 3B cells was 9.9 hours when cultured without DFO, but it was markedly prolonged (54.1 hours) after the addition of 20 micrograms/ml of DFO. After removal of DFO from the culture media following 24 hours of incubation with 20 micrograms/ml of DFO, a sequential increase from early through mid and late-S to G2/M phase was observed. In conclusion, the antiproliferative effect of DFO on cultured human hepatoma cell lines was caused by the inhibition of DNA synthesis which was related to a block in the early-mid S interface or mid S phase of the cell cycle.
D Y Kim; W H Kim; J K Kang; S Park; O H Kwon
Related Documents :
6795178 - Cell wall synthesis and initiation of deoxyribonucleic acid replication in bacillus sub...
7194418 - Lack of coupling between dna and histone synthesis in growth-arrested friend erythroleu...
558048 - Induction of hyperplasia and its suppression by hydrocortisone in organ-cultured rat ur...
23887378 - A primary culture system of mouse thick ascending limb cells with preserved function an...
6361548 - The neurotoxins 2,5-hexanedione and acrylamide promote aggregation of intermediate fila...
3254818 - Prevention of spinal neural tube defects in the mouse embryo by growth retardation duri...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Yonsei medical journal     Volume:  35     ISSN:  0513-5796     ISO Abbreviation:  Yonsei Med. J.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-07-21     Completed Date:  1994-07-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0414003     Medline TA:  Yonsei Med J     Country:  KOREA    
Other Details:
Languages:  eng     Pagination:  62-71     Citation Subset:  IM    
Department of Internal Medicine, Ewha Womans University Medical College, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bromodeoxyuridine / diagnostic use
Carcinoma, Hepatocellular / pathology*
Cell Cycle / drug effects
Cell Division / drug effects
Deferoxamine / pharmacology*
Flow Cytometry
Liver Neoplasms / pathology*
Tumor Cells, Cultured / drug effects
Reg. No./Substance:
59-14-3/Bromodeoxyuridine; 70-51-9/Deferoxamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intra-carotid thrombolytic therapy in acute ischemic stroke of carotid arterial territory.
Next Document:  In vitro pressure drop comparison between two mechanical valve prostheses.